The global market size was valued at US$ 3.45 billion in 2024 and is projected to reach US$ 5.67 billion by 2030, at a CAGR of 8.6% during the forecast period 2024-2030.
The United States market size was valued at US$ 1.23 billion in 2024 and is projected to reach US$ 1.98 billion by 2030, at a CAGR of 8.2% during the forecast period 2024-2030.
Targeted cancer therapies inhibiting BRAF kinase.
Clinical trials reached 156 in 2023. Novel compounds grow at 9.8% annually. Market saw 48% increase in combination therapies. Approvals obtained in 38 countries. Future investments of US$ 2.34 billion planned by 2026. North America leads with 46% market share.
Report Overview
BRAF kinase inhibitors are generally used as targeted therapy drugs for the treatment of carcinomas such as RCC, NSCLC, and melanomas caused by mutations of the BRAF gene.
This report provides a deep insight into the global BRAF Kinase Inhibitors market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global BRAF Kinase Inhibitors Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the BRAF Kinase Inhibitors market in any manner.
Global BRAF Kinase Inhibitors Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Array BioPharma Inc.
Bayer AG
F. Hoffmann-La Roche Ltd.
Novartis AG
Market Segmentation (by Type)
Dabrafenib
Sorafenib
Vemurafenib
Encorafenib
Market Segmentation (by Application)
Hospital
Medical Research Institute
Clinic
Other
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the BRAF Kinase Inhibitors Market
Overview of the regional outlook of the BRAF Kinase Inhibitors Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value (USD Billion) data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of BRAF Kinase Inhibitors
1.2 Key Market Segments
1.2.1 BRAF Kinase Inhibitors Segment by Type
1.2.2 BRAF Kinase Inhibitors Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 BRAF Kinase Inhibitors Market Overview
2.1 Global Market Overview
2.1.1 Global BRAF Kinase Inhibitors Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global BRAF Kinase Inhibitors Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 BRAF Kinase Inhibitors Market Competitive Landscape
3.1 Global BRAF Kinase Inhibitors Sales by Manufacturers (2019-2024)
3.2 Global BRAF Kinase Inhibitors Revenue Market Share by Manufacturers (2019-2024)
3.3 BRAF Kinase Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global BRAF Kinase Inhibitors Average Price by Manufacturers (2019-2024)
3.5 Manufacturers BRAF Kinase Inhibitors Sales Sites, Area Served, Product Type
3.6 BRAF Kinase Inhibitors Market Competitive Situation and Trends
3.6.1 BRAF Kinase Inhibitors Market Concentration Rate
3.6.2 Global 5 and 10 Largest BRAF Kinase Inhibitors Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 BRAF Kinase Inhibitors Industry Chain Analysis
4.1 BRAF Kinase Inhibitors Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of BRAF Kinase Inhibitors Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 BRAF Kinase Inhibitors Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global BRAF Kinase Inhibitors Sales Market Share by Type (2019-2024)
6.3 Global BRAF Kinase Inhibitors Market Size Market Share by Type (2019-2024)
6.4 Global BRAF Kinase Inhibitors Price by Type (2019-2024)
7 BRAF Kinase Inhibitors Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global BRAF Kinase Inhibitors Market Sales by Application (2019-2024)
7.3 Global BRAF Kinase Inhibitors Market Size (M USD) by Application (2019-2024)
7.4 Global BRAF Kinase Inhibitors Sales Growth Rate by Application (2019-2024)
8 BRAF Kinase Inhibitors Market Segmentation by Region
8.1 Global BRAF Kinase Inhibitors Sales by Region
8.1.1 Global BRAF Kinase Inhibitors Sales by Region
8.1.2 Global BRAF Kinase Inhibitors Sales Market Share by Region
8.2 North America
8.2.1 North America BRAF Kinase Inhibitors Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe BRAF Kinase Inhibitors Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific BRAF Kinase Inhibitors Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America BRAF Kinase Inhibitors Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa BRAF Kinase Inhibitors Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Array BioPharma Inc.
9.1.1 Array BioPharma Inc. BRAF Kinase Inhibitors Basic Information
9.1.2 Array BioPharma Inc. BRAF Kinase Inhibitors Product Overview
9.1.3 Array BioPharma Inc. BRAF Kinase Inhibitors Product Market Performance
9.1.4 Array BioPharma Inc. Business Overview
9.1.5 Array BioPharma Inc. BRAF Kinase Inhibitors SWOT Analysis
9.1.6 Array BioPharma Inc. Recent Developments
9.2 Bayer AG
9.2.1 Bayer AG BRAF Kinase Inhibitors Basic Information
9.2.2 Bayer AG BRAF Kinase Inhibitors Product Overview
9.2.3 Bayer AG BRAF Kinase Inhibitors Product Market Performance
9.2.4 Bayer AG Business Overview
9.2.5 Bayer AG BRAF Kinase Inhibitors SWOT Analysis
9.2.6 Bayer AG Recent Developments
9.3 F. Hoffmann-La Roche Ltd.
9.3.1 F. Hoffmann-La Roche Ltd. BRAF Kinase Inhibitors Basic Information
9.3.2 F. Hoffmann-La Roche Ltd. BRAF Kinase Inhibitors Product Overview
9.3.3 F. Hoffmann-La Roche Ltd. BRAF Kinase Inhibitors Product Market Performance
9.3.4 F. Hoffmann-La Roche Ltd. BRAF Kinase Inhibitors SWOT Analysis
9.3.5 F. Hoffmann-La Roche Ltd. Business Overview
9.3.6 F. Hoffmann-La Roche Ltd. Recent Developments
9.4 Novartis AG
9.4.1 Novartis AG BRAF Kinase Inhibitors Basic Information
9.4.2 Novartis AG BRAF Kinase Inhibitors Product Overview
9.4.3 Novartis AG BRAF Kinase Inhibitors Product Market Performance
9.4.4 Novartis AG Business Overview
9.4.5 Novartis AG Recent Developments
10 BRAF Kinase Inhibitors Market Forecast by Region
10.1 Global BRAF Kinase Inhibitors Market Size Forecast
10.2 Global BRAF Kinase Inhibitors Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe BRAF Kinase Inhibitors Market Size Forecast by Country
10.2.3 Asia Pacific BRAF Kinase Inhibitors Market Size Forecast by Region
10.2.4 South America BRAF Kinase Inhibitors Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of BRAF Kinase Inhibitors by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global BRAF Kinase Inhibitors Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of BRAF Kinase Inhibitors by Type (2025-2030)
11.1.2 Global BRAF Kinase Inhibitors Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of BRAF Kinase Inhibitors by Type (2025-2030)
11.2 Global BRAF Kinase Inhibitors Market Forecast by Application (2025-2030)
11.2.1 Global BRAF Kinase Inhibitors Sales (Kilotons) Forecast by Application
11.2.2 Global BRAF Kinase Inhibitors Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. BRAF Kinase Inhibitors Market Size Comparison by Region (M USD)
Table 5. Global BRAF Kinase Inhibitors Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global BRAF Kinase Inhibitors Sales Market Share by Manufacturers (2019-2024)
Table 7. Global BRAF Kinase Inhibitors Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global BRAF Kinase Inhibitors Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in BRAF Kinase Inhibitors as of 2022)
Table 10. Global Market BRAF Kinase Inhibitors Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers BRAF Kinase Inhibitors Sales Sites and Area Served
Table 12. Manufacturers BRAF Kinase Inhibitors Product Type
Table 13. Global BRAF Kinase Inhibitors Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of BRAF Kinase Inhibitors
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. BRAF Kinase Inhibitors Market Challenges
Table 22. Global BRAF Kinase Inhibitors Sales by Type (Kilotons)
Table 23. Global BRAF Kinase Inhibitors Market Size by Type (M USD)
Table 24. Global BRAF Kinase Inhibitors Sales (Kilotons) by Type (2019-2024)
Table 25. Global BRAF Kinase Inhibitors Sales Market Share by Type (2019-2024)
Table 26. Global BRAF Kinase Inhibitors Market Size (M USD) by Type (2019-2024)
Table 27. Global BRAF Kinase Inhibitors Market Size Share by Type (2019-2024)
Table 28. Global BRAF Kinase Inhibitors Price (USD/Ton) by Type (2019-2024)
Table 29. Global BRAF Kinase Inhibitors Sales (Kilotons) by Application
Table 30. Global BRAF Kinase Inhibitors Market Size by Application
Table 31. Global BRAF Kinase Inhibitors Sales by Application (2019-2024) & (Kilotons)
Table 32. Global BRAF Kinase Inhibitors Sales Market Share by Application (2019-2024)
Table 33. Global BRAF Kinase Inhibitors Sales by Application (2019-2024) & (M USD)
Table 34. Global BRAF Kinase Inhibitors Market Share by Application (2019-2024)
Table 35. Global BRAF Kinase Inhibitors Sales Growth Rate by Application (2019-2024)
Table 36. Global BRAF Kinase Inhibitors Sales by Region (2019-2024) & (Kilotons)
Table 37. Global BRAF Kinase Inhibitors Sales Market Share by Region (2019-2024)
Table 38. North America BRAF Kinase Inhibitors Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe BRAF Kinase Inhibitors Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific BRAF Kinase Inhibitors Sales by Region (2019-2024) & (Kilotons)
Table 41. South America BRAF Kinase Inhibitors Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa BRAF Kinase Inhibitors Sales by Region (2019-2024) & (Kilotons)
Table 43. Array BioPharma Inc. BRAF Kinase Inhibitors Basic Information
Table 44. Array BioPharma Inc. BRAF Kinase Inhibitors Product Overview
Table 45. Array BioPharma Inc. BRAF Kinase Inhibitors Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Array BioPharma Inc. Business Overview
Table 47. Array BioPharma Inc. BRAF Kinase Inhibitors SWOT Analysis
Table 48. Array BioPharma Inc. Recent Developments
Table 49. Bayer AG BRAF Kinase Inhibitors Basic Information
Table 50. Bayer AG BRAF Kinase Inhibitors Product Overview
Table 51. Bayer AG BRAF Kinase Inhibitors Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Bayer AG Business Overview
Table 53. Bayer AG BRAF Kinase Inhibitors SWOT Analysis
Table 54. Bayer AG Recent Developments
Table 55. F. Hoffmann-La Roche Ltd. BRAF Kinase Inhibitors Basic Information
Table 56. F. Hoffmann-La Roche Ltd. BRAF Kinase Inhibitors Product Overview
Table 57. F. Hoffmann-La Roche Ltd. BRAF Kinase Inhibitors Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. F. Hoffmann-La Roche Ltd. BRAF Kinase Inhibitors SWOT Analysis
Table 59. F. Hoffmann-La Roche Ltd. Business Overview
Table 60. F. Hoffmann-La Roche Ltd. Recent Developments
Table 61. Novartis AG BRAF Kinase Inhibitors Basic Information
Table 62. Novartis AG BRAF Kinase Inhibitors Product Overview
Table 63. Novartis AG BRAF Kinase Inhibitors Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Novartis AG Business Overview
Table 65. Novartis AG Recent Developments
Table 66. Global BRAF Kinase Inhibitors Sales Forecast by Region (2025-2030) & (Kilotons)
Table 67. Global BRAF Kinase Inhibitors Market Size Forecast by Region (2025-2030) & (M USD)
Table 68. North America BRAF Kinase Inhibitors Sales Forecast by Country (2025-2030) & (Kilotons)
Table 69. North America BRAF Kinase Inhibitors Market Size Forecast by Country (2025-2030) & (M USD)
Table 70. Europe BRAF Kinase Inhibitors Sales Forecast by Country (2025-2030) & (Kilotons)
Table 71. Europe BRAF Kinase Inhibitors Market Size Forecast by Country (2025-2030) & (M USD)
Table 72. Asia Pacific BRAF Kinase Inhibitors Sales Forecast by Region (2025-2030) & (Kilotons)
Table 73. Asia Pacific BRAF Kinase Inhibitors Market Size Forecast by Region (2025-2030) & (M USD)
Table 74. South America BRAF Kinase Inhibitors Sales Forecast by Country (2025-2030) & (Kilotons)
Table 75. South America BRAF Kinase Inhibitors Market Size Forecast by Country (2025-2030) & (M USD)
Table 76. Middle East and Africa BRAF Kinase Inhibitors Consumption Forecast by Country (2025-2030) & (Units)
Table 77. Middle East and Africa BRAF Kinase Inhibitors Market Size Forecast by Country (2025-2030) & (M USD)
Table 78. Global BRAF Kinase Inhibitors Sales Forecast by Type (2025-2030) & (Kilotons)
Table 79. Global BRAF Kinase Inhibitors Market Size Forecast by Type (2025-2030) & (M USD)
Table 80. Global BRAF Kinase Inhibitors Price Forecast by Type (2025-2030) & (USD/Ton)
Table 81. Global BRAF Kinase Inhibitors Sales (Kilotons) Forecast by Application (2025-2030)
Table 82. Global BRAF Kinase Inhibitors Market Size Forecast by Application (2025-2030) & (M USD)
List of Figures
Figure 1. Product Picture of BRAF Kinase Inhibitors
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global BRAF Kinase Inhibitors Market Size (M USD), 2019-2030
Figure 5. Global BRAF Kinase Inhibitors Market Size (M USD) (2019-2030)
Figure 6. Global BRAF Kinase Inhibitors Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. BRAF Kinase Inhibitors Market Size by Country (M USD)
Figure 11. BRAF Kinase Inhibitors Sales Share by Manufacturers in 2023
Figure 12. Global BRAF Kinase Inhibitors Revenue Share by Manufacturers in 2023
Figure 13. BRAF Kinase Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market BRAF Kinase Inhibitors Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by BRAF Kinase Inhibitors Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global BRAF Kinase Inhibitors Market Share by Type
Figure 18. Sales Market Share of BRAF Kinase Inhibitors by Type (2019-2024)
Figure 19. Sales Market Share of BRAF Kinase Inhibitors by Type in 2023
Figure 20. Market Size Share of BRAF Kinase Inhibitors by Type (2019-2024)
Figure 21. Market Size Market Share of BRAF Kinase Inhibitors by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global BRAF Kinase Inhibitors Market Share by Application
Figure 24. Global BRAF Kinase Inhibitors Sales Market Share by Application (2019-2024)
Figure 25. Global BRAF Kinase Inhibitors Sales Market Share by Application in 2023
Figure 26. Global BRAF Kinase Inhibitors Market Share by Application (2019-2024)
Figure 27. Global BRAF Kinase Inhibitors Market Share by Application in 2023
Figure 28. Global BRAF Kinase Inhibitors Sales Growth Rate by Application (2019-2024)
Figure 29. Global BRAF Kinase Inhibitors Sales Market Share by Region (2019-2024)
Figure 30. North America BRAF Kinase Inhibitors Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America BRAF Kinase Inhibitors Sales Market Share by Country in 2023
Figure 32. U.S. BRAF Kinase Inhibitors Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada BRAF Kinase Inhibitors Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico BRAF Kinase Inhibitors Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe BRAF Kinase Inhibitors Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe BRAF Kinase Inhibitors Sales Market Share by Country in 2023
Figure 37. Germany BRAF Kinase Inhibitors Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France BRAF Kinase Inhibitors Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. BRAF Kinase Inhibitors Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy BRAF Kinase Inhibitors Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia BRAF Kinase Inhibitors Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific BRAF Kinase Inhibitors Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific BRAF Kinase Inhibitors Sales Market Share by Region in 2023
Figure 44. China BRAF Kinase Inhibitors Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan BRAF Kinase Inhibitors Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea BRAF Kinase Inhibitors Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India BRAF Kinase Inhibitors Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia BRAF Kinase Inhibitors Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America BRAF Kinase Inhibitors Sales and Growth Rate (Kilotons)
Figure 50. South America BRAF Kinase Inhibitors Sales Market Share by Country in 2023
Figure 51. Brazil BRAF Kinase Inhibitors Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina BRAF Kinase Inhibitors Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia BRAF Kinase Inhibitors Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa BRAF Kinase Inhibitors Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa BRAF Kinase Inhibitors Sales Market Share by Region in 2023
Figure 56. Saudi Arabia BRAF Kinase Inhibitors Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE BRAF Kinase Inhibitors Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt BRAF Kinase Inhibitors Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria BRAF Kinase Inhibitors Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa BRAF Kinase Inhibitors Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global BRAF Kinase Inhibitors Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global BRAF Kinase Inhibitors Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global BRAF Kinase Inhibitors Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global BRAF Kinase Inhibitors Market Share Forecast by Type (2025-2030)
Figure 65. Global BRAF Kinase Inhibitors Sales Forecast by Application (2025-2030)
Figure 66. Global BRAF Kinase Inhibitors Market Share Forecast by Application (2025-2030)
